ijerph-logo

Journal Browser

Journal Browser

Ophthalmic Molecular Genetics and Eye Diseases

A special issue of International Journal of Environmental Research and Public Health (ISSN 1660-4601). This special issue belongs to the section "Global Health".

Deadline for manuscript submissions: closed (31 March 2022) | Viewed by 399

Special Issue Editors


E-Mail Website
Guest Editor
Department of Medical Genetics, Poznan University of Medical Sciences, 60-806 Poznan, Poland
Interests: ophthalmogenetics; retinal dystrophies; optic nerve atrophies; aniridia; eye malformations; cilliopathies; ocular gene therapy

E-Mail Website
Guest Editor
Department of Medical Genetics, Poznan University of Medical Sciences, 60-806 Poznan, Poland
Interests: ophthalmogenetics; retinal dystrophies; optic nerve atrophies; aniridia, eye malformations; cilliopathies; ocular gene therapy

Special Issue Information

Dear Colleagues,

Ophthalmology has played a special role in the development of human genetics. It is one of the two most common clinical specialties alongside neurology to be involved in genetic disorders. Retinoblastoma was the first human cancer gene to be cloned. Leber hereditary optic neuropathy was the first mitochondrial disorder described. X-Linked red-green color deficiency was the first X-linked disorder featured.

Although hereditary eye diseases are rare, genetic factors are a significant cause of childhood blindness and lead to visual impairment in adults globally. The OMIM database currently includes 1600 inherited human diseases with significant eye pathology, and the RetNet database lists over 300 genes responsible for retinal dystrophies only. For these reasons, genetically determined diseases of the visual system deserve a separate subspecialty in clinical genetics: ophthalmogenetics.

Advances in molecular genetics over the past three decades have helped to identify a substantial number of genetic variants and conditions known to contribute to eye diseases. This gives a chance for precise diagnosis and the best possible management, including genetic counselling, for our patients. Advances in gene therapy maintain extensive promise for the cure of hereditary ophthalmic condition.

Papers addressing these topics are invited for this Special Issue, especially those combining a high academic standard coupled with a practical focus on the clinical aspects of hereditary eye diseases.

Prof. Dr. Maciej R. Krawczyński
Dr. Anna Wawrocka
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Environmental Research and Public Health is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2500 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • ophthalmogenetics
  • inherited retinal dystrophies
  • hereditary optic neuropathies
  • eye malformations
  • gene therapy in ocular disorders

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop